{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20200825",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "64417",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/212028Orig1s002ltr.pdf",
              "date": "20200825",
              "type": "Letter"
            },
            {
              "id": "64462",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212028s002lbl.pdf",
              "date": "20200901",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20250219",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "81295",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212028s011lbl.pdf",
              "date": "20250220",
              "type": "Label"
            },
            {
              "id": "81296",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212028s011lbl.pdf#page=20",
              "date": "20250220",
              "type": "Medication Guide"
            },
            {
              "id": "81304",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/212028Orig1s011ltr.pdf",
              "date": "20250221",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20230125",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73295",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/212028Orig1s007ltr.pdf",
              "date": "20230126",
              "type": "Letter"
            },
            {
              "id": "73313",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s007lbl.pdf",
              "date": "20230130",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20191220",
          "submission_public_notes": "FR Notice on DEA Scheduling; Date of Approval  April 7, 2020",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "61376",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf",
              "date": "20191223",
              "type": "Label"
            },
            {
              "id": "61448",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/212028Orig1s000ltr.pdf",
              "date": "20191226",
              "type": "Letter"
            },
            {
              "id": "61713",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212028Orig1s000TOC.html",
              "date": "20200128",
              "type": "Review"
            },
            {
              "id": "68931",
              "url": "https://www.federalregister.gov/documents/2020/04/07/2020-07089/schedules-of-controlled-substances-placement-of-lemborexant-in-schedule-iv",
              "date": "20211008",
              "type": "Federal Register Notice"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20230420",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "74035",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/212028Orig1s008ltr.pdf",
              "date": "20230421",
              "type": "Letter"
            },
            {
              "id": "74048",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf",
              "date": "20230424",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20220311",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "70504",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212028Orig1s006ltr.pdf",
              "date": "20220314",
              "type": "Letter"
            },
            {
              "id": "70524",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212028s006lbl.pdf",
              "date": "20220315",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA212028",
      "sponsor_name": "EISAI INC",
      "openfda": {
        "application_number": [
          "NDA212028"
        ],
        "brand_name": [
          "DAYVIGO"
        ],
        "generic_name": [
          "LEMBOREXANT"
        ],
        "manufacturer_name": [
          "Eisai Inc."
        ],
        "product_ndc": [
          "62856-405",
          "62856-410",
          "62856-455"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LEMBOREXANT"
        ],
        "rxcui": [
          "2272408",
          "2272414",
          "2288425",
          "2288427"
        ],
        "spl_id": [
          "c82838dc-6934-4541-8a02-bd44ee5bb82a"
        ],
        "spl_set_id": [
          "7074cb65-77b3-45d2-8e8d-da8dc0f70bfd"
        ],
        "package_ndc": [
          "62856-405-30",
          "62856-405-90",
          "62856-405-10",
          "62856-410-30",
          "62856-410-90",
          "62856-455-10"
        ],
        "nui": [
          "N0000191000",
          "N0000190998",
          "N0000187064"
        ],
        "pharm_class_epc": [
          "Orexin Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Orexin Receptor Antagonists [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]"
        ],
        "unii": [
          "0K5743G68X"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "DAYVIGO",
          "active_ingredients": [
            {
              "name": "LEMBOREXANT",
              "strength": "10MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "DAYVIGO",
          "active_ingredients": [
            {
              "name": "LEMBOREXANT",
              "strength": "5MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}